CellCarta is a global contract research organization providing testing services including biomarker solutions, immune monitoring, proteomics, genomics, histopathology, and regulatory expertise. This description is self-described as the company offers advanced scientific capabilities to support therapeutic development.

CellCarta

CellCarta | 24,476 followers on LinkedIn. As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. 

CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services.

Mark Watson

Senior Financial Analyst

Anna-Maria Leoci

Co-founder and Vice-Chairman at CellCarta

Martin LeBlanc

Christopher Ung

⭐ Live from #SITC2024 ! Catch Elizabeth Ross and Mark Kockx presenting poster #126 on developing a visual scoring method to determine inflamed, excluded or desert immune phenotype in NSCLC, colorectal, and urothelial cancers. Missed yesterday’s posters. No worries, Damien Montamat-Sicotte and Jean-Philippe Goulet are still at Booth 1310, ready to chat about cytometry analysis (#833) and advanced CITE-seq data (#163). Stop by to connect. #PrecisionMedicine #Immunooncology #Biomarkers

Think you’ve got what it takes to top the leaderboard? 🎮 Swing by Booth #1310 and prove it! Ready, set, game on! 💥 See you there!

Hello from the team at #SITC2024 ! 👋 We’d love to chat about your latest scientific challenges and how we can support your immunotherapy research. Drop by Booth 1310 or book a meeting here 👇 https://bit.ly/3HQzLHL See you there!

Can you clear the competition at #SITC2024 ? Put your gaming skills to the test, visit Booth 1310! 🕹️

Today is #InternationalPathologyDay ! 🔬 Let’s take a moment to recognize the skilled pathologists working tirelessly to guide treatments, and advance research. At CellCarta, we really don’t know where we’d be without our own talented team of pathologists. Meet the team here 👉 https://lnkd.in/g-sQqaT8

#SITC2024 is starting tomorrow! Don’t miss our three posters: ⭐ Abstract 126: Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in non-small cell lung cancer, colorectal cancer, and urothelial cancer ⭐ Abstract 833: Accelerating analysis of cytometry data sets leveraging a visualization tool built within CellEngine, a cloud-based cytometry analysis software ⭐ Abstract 163: Analyzing CITE-seq data like an immunologist with a hybrid hierarchical gating approach in CellEngine software Stop by the posters and book a meeting with our team to find out more! https://bit.ly/3HQzLHL #PrecisionMedicine #Immunooncology #Biomarkers Show Less

Did you know CellCarta offers kitting solutions to facilitate the logistics of PK and biomarker samples during clinical trials? Our team of experts collaborates with you to ensure kits are tailored to your needs. Check out our services: https://bit.ly/3YRjyJN #CellCarta #CROLaboratory #Precisionmedicine

Our Naperville laboratory is upgrading its genomic capabilities with the NovaSeq X Plus sequencing instrument. This exciting development means we are now able to provide our customers with: ✔️Faster sequencing times ✔️Increased throughout ✔️Improved cost efficiency We are delighted to bring these benefits to you, and to continue to utilize the latest innovations in sequencing to support your research. Learn more: https://bit.ly/3URAuzt #Genomics #PrecisionMedicine #PCR #CellCarta

PBMC processing following robust, standardized SOPs to ensure quality data. Sounds interesting? https://bit.ly/4foNlll Our state-of-the-art facility in Naperville, U.S. offers PBMC processing and delivers: ⭐ Fast turn arounds to support short stability windows, with samples collected, shipped and processed within 24hrs ⭐ Capabilities with both Ficoll and CPT tubes that lead to >90% cell viability ⭐ Onsite biorepository services Discover why we’re the CRO partner of choice for PBMC processing, but also sample logistics the world over. 🌏 https://bit.ly/4cSIvuL #CellCarta #PrecisionMedicine #CellTherapy

Unsure how to transition your clinical trial assay to companion diagnostic (CDx)? Our experts can help. Learn more here 👉 https://bit.ly/3qALZ2d #CellCarta #ClinicalTrials #PrecisionMedicine

msh id	COM:CELLCARTA
symbol	-
name	CellCarta
homepage url	https://cellcarta.com
country	US
sector	Healthcare & Health Services
industry	Contract Research Organization
market	PRIVATE
employee count	-
crunchbase url	-
linkedin url	https://www.linkedin.com/company/cellcarta
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

CELL

COM:CELLCARTA

CellCarta

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-